"The 2012 year saw heavy R&D investments made into our SMART Monitoring, GEMS 4.0 and our ECG viewer GUAVA II technologies, securing several important clearances and bringing the HeartCheck PEN to market. Our efforts in the 2013 fiscal year will focus on integration of wearable ECG devices into the SMART Monitoring solution and closing distribution and sales contracts for the HeartCheck PEN," said Etienne Grima, CEO of CardioComm Solutions. "The terms of this $1M LOC are extremely favourable and, if needed, will greatly assist CardioComm Solutions to manage costs and provide some flexibility on the time to close agreements that are under review."